Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 409-414, February 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Byfield, P. E.
Right arrow Articles by Imagawa, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Byfield, P. E.
Right arrow Articles by Imagawa, D. T.

The Role of Serum Factors in the Acceleration by Freund's Complete Adjuvant of the Growth of Transplanted Murine Leukemic Cells1

Patricia E. Byfield, Jerry Z. Finklestein, Karen L. Tittle, Connie Hsi and David T. Imagawa

Department of Pediatrics, UCLA School of Medicine, Harbor General Hospital Campus,2 Torrance, California 90509 [P. E. B., J. Z. F., K. L. T., C. H., D. T. I.], and Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, California 90024 [P. E. B., D. T. I.]

Attempted nonspecific immunotherapy led to acceleration rather than retardation of tumor growth. Mice given injections of Freund's adjuvant were more susceptible to transplanted syngeneic Gross virus-induced leukemic cells when Freund's complete adjuvant was administered i.p. 0 to 7 days before or 1 day after tumor; thereafter, the adjuvant had no effect.

Two serum-mediated phenomena were demonstrated in vitro: (a) sera from mice immunized with Freund's complete adjuvant and tumor facilitated killing of tumor cells by peritoneal exudate cells from nonimmune mice; (b) sera from all mice with progressive tumor blocked the cytotoxicity of a xenogeneic tumor-specific serum.

Certain sera produced both effects. However, sera that either blocked or facilitated tumor killing in vitro had no effect on the growth in vivo of transplanted tumor cells.

1 Supported in part by Cancer Research Funds of the University of California; The California Institute for Cancer Research; American Cancer Society, California Division Special Grant 568; National American Cancer Society Grant E-451B; National Cancer Institute Grant CA 08930; and the Mark Richardson Memorial Fund. Results included here were presented in part at the 15th Annual Meeting of the American Society of Hematology, Hollywood, Fla., December 1972.

2 Address reprint requests here.

Received 4/13/73. Accepted 11/ 5/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.